Eprinomectin for Goat: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Eprinomectin is a macrocyclic lactone antiparasitic used to treat certain internal and external parasites in ruminants. It is closely related to ivermectin and moxidectin, but it was developed to have lower transfer into milk than some other drugs in the same family. That matters for dairy animals and for goat herds where milk-withdrawal planning is a major concern.

In goats, eprinomectin is most often discussed as a dewormer or endectocide. Depending on the product and country, it may be available as a pour-on and, in some markets outside the U.S., as formulations specifically authorized for sheep and goats. In the United States, goat use may be extra-label, which means your vet must decide whether it is appropriate, legal, and practical for your herd.

Goats do not process many parasite medications the same way cattle do. They often have different absorption and clearance patterns, so a cattle label should not be copied over to goats without veterinary guidance. Research in goats has shown that pour-on eprinomectin can have variable absorption, which is one reason your vet may pair treatment decisions with fecal testing and follow-up monitoring.

For pet parents with dairy goats, the biggest question is often milk safety. Eprinomectin is attractive because it has very low milk partitioning compared with some other macrocyclic lactones, but withdrawal guidance still depends on the exact product, route, country label, and whether the use is extra-label. Your vet should make that call for your specific animals and intended milk use.

Eprinomectin is used in goats for susceptible parasite infections, especially gastrointestinal nematodes and lungworms. In practice, your vet may consider it when there is concern for parasites such as barber pole worm and other strongyles, or when a herd has ongoing parasite pressure that needs a broader control plan rather than repeated guesswork.

It may also be used for some external parasites, including certain lice or mite problems, depending on the diagnosis and the product being used. That said, not every itchy goat has mites, and not every thin goat has worms. Weight loss, anemia, rough hair coat, bottle jaw, coughing, and poor growth can have several causes, so treatment should be based on an exam, fecal testing, FAMACHA scoring when appropriate, and herd history.

One important limitation is parasite resistance. The FDA notes that resistance has developed to every major dewormer class used in small ruminants, and that includes drugs used against common goat parasites. Because of that, eprinomectin should not be treated like a routine calendar product. Your vet may recommend targeted treatment, fecal egg counts, or a fecal egg count reduction test to see whether the medication is still working on your farm.

For lactating dairy goats, eprinomectin may be considered when milk-withdrawal concerns make other options less practical. Even then, the right choice depends on the exact parasite problem, local resistance patterns, and whether the product is being used according to an approved goat label or under extra-label veterinary direction.

Do not dose eprinomectin in a goat without your vet's instructions. Goat dosing is product-specific, route-specific, and strongly affected by whether the use is labeled or extra-label. Using a cattle dose in a goat can lead to underdosing, treatment failure, and faster parasite resistance.

Published goat data and product information from markets where goat labeling exists show that pour-on eprinomectin for goats is commonly dosed at 1 mg/kg topically, which corresponds to 2 mL per 10 kg body weight for a 5 mg/mL product. By contrast, the common cattle pour-on dose is 0.5 mg/kg, and older goat pharmacokinetic work suggests that cattle-style pour-on dosing may not provide adequate exposure in goats. Some goat-labeled products outside the U.S. also list injectable eprinomectin at 0.2 mg/kg, but injectable use should only be discussed with your vet because route, withdrawal times, and legality vary by product and country.

Accurate body weight matters. Estimating by eye often leads to underdosing in goats. Your vet may recommend weighing the goat, clipping or parting heavy hair before topical application if needed, and applying the product exactly where the label or prescription directs. In dairy goats, your vet should also give you a clear meat and milk withdrawal plan in writing.

Because resistance is common in small ruminants, dosing is only one part of treatment. Your vet may recommend a fecal egg count before treatment, then a follow-up fecal egg count reduction test about 10 to 14 days later to confirm the drug actually worked in your herd.

Most goats tolerate eprinomectin reasonably well when it is used correctly, but side effects and treatment failures can still happen. Mild problems may include skin irritation at the application site, temporary restlessness after a pour-on, or reduced appetite for a short period. If a goat licks recently applied product, drooling or brief digestive upset may occur.

More serious concerns are usually tied to overdose, wrong route, wrong species use, or severe parasite burden rather than the drug alone. Macrocyclic lactones can cause neurologic toxicity when exposure is too high. Warning signs can include weakness, depression, stumbling, tremors, dilated pupils, poor suckle, inability to rise, or coma. See your vet immediately if any of these signs appear after treatment.

Another practical side effect is not a visible reaction but lack of efficacy. If a goat still looks anemic, continues losing weight, keeps coughing, or has persistently high fecal egg counts after treatment, resistance or underdosing may be the problem. That is common enough in goats that your vet should not assume the medication failed because the goat was "too sick."

For dairy herds, there is also a food-safety angle. Even though eprinomectin is known for low milk transfer, extra-label use in food animals requires veterinary oversight. If your goat is producing milk or may enter the food chain, ask your vet for exact withdrawal instructions before treatment.

There are no widely cited day-to-day drug interactions that pet parents commonly manage at home with eprinomectin in goats, but that does not mean interactions are impossible. The biggest real-world concern is combining eprinomectin with other dewormers or antiparasitic products without a plan, which can increase the risk of dosing errors, unnecessary drug exposure, and resistance pressure.

Because eprinomectin is a macrocyclic lactone, your vet will be cautious about stacking it with other drugs in the same family, such as ivermectin, doramectin, or moxidectin, unless there is a specific medical reason. Using multiple products from the same class close together does not automatically improve parasite control and may increase toxicity risk.

Your vet may also review the goat's overall health before prescribing it. Animals that are very young, debilitated, dehydrated, or dealing with significant liver stress may need a more careful plan. In other species, macrocyclic lactones can have increased neurologic risk when blood-brain barrier protection is impaired, so any goat showing neurologic disease should be assessed before treatment.

Finally, food-animal rules matter as much as pharmacology. If your goat is used for milk or meat, tell your vet about every medication, supplement, and recent dewormer the animal has received. That helps your vet avoid conflicting withdrawal recommendations and choose the safest parasite-control option for your herd.